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H2-M3–restricted CD8+ T cells are not 
required for MHC class Ib–restricted 
immunity against Listeria monocytogenes 
Sarah E.F. D’Orazio,1 Christine A. Shaw,2 and Michael N. Starnbach2
1Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine, 
Lexington, KY 40536
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Studies using major histocompatibility complex (MHC)-Ia–defi  cient mice have shown that 
MHC-Ib–restricted CD8+ T cells can clear infections caused by intracellular pathogens such 
as Listeria monocytogenes. M3-restricted CD8+ T cells, which recognize short hydrophobic 
N-formylated peptides, appear to comprise a substantial portion of the MHC-Ib–restricted 
T cell response in the mouse model of L. monocytogenes infection. In this study, we isolated 
formyltransferase (fmt) mutant strains of L. monocytogenes that lacked the ability to add 
formyl groups to nascent polypeptides. These fmt mutant Listeria strains did not produce 
antigens that could be recognized by M3-restricted T cells. We showed that immunization 
of MHC-Ia–defi  cient mice with fmt mutant Listeria resulted in stimulation of a protective 
memory response that cleared subsequent challenge with wild-type L. monocytogenes, 
despite the fact that M3-restricted CD8+ T cells did not proliferate in these mice. These 
data suggest that M3-restricted T cells are not required for protection against L. monocy-
togenes and underscore the importance of searching for new antigen-presenting molecules 
among the large MHC-Ib family of proteins.
Although innate immune responses are essential 
to limit the spread of intracellular bacterial in-
fections, it is the adaptive immune response that 
allows the body to completely clear tremendous 
bacterial burdens. Memory CD8+ T cells that 
recognize antigens presented by MHC-I on the 
surface of infected cells are generally thought to 
be required for clearance of intracellular path-
ogens. Mice express two groups of MHC-I 
proteins: (a) the classically studied MHC-Ia mol-
ecules (K, D, and L) and (b) the nonclassical or 
MHC-Ib proteins, including Q, T, and M gene 
products. Much eff  ort has been devoted to iden-
tifying peptide antigens within bacterial proteins 
that are predicted to bind to classical MHC-I 
molecules. For example, at least four dominant 
Kd-binding epitopes derived from secreted viru-
lence factors are known to be presented during 
Listeria monocytogenes infection, and several other 
subdominant epitopes have also been identifi  ed 
(1, 2). However, in recent years, it has become 
increasingly clear that the nonclassical MHC-Ib 
molecules can also present antigens to T cells 
during bacterial infection (3).
Nonclassical MHC-I molecules are a widely 
diverse set of proteins encoded both within and 
outside the MHC locus that have been collec-
tively referred to as MHC-Ib. It is diffi   cult to 
make generalizations about MHC-Ib mole-
cules because of the diversity of the members of 
this protein family; however, many diff  erences 
from classical MHC-I have been observed. 
Cell surface levels of many MHC-Ib proteins 
are lower than MHC-Ia and some MHC-Ib 
molecules display a tissue-specifi  c  expression 
pattern, unlike MHC-Ia molecules that are 
ubiquitously expressed (4, 5). MHC-Ib mole-
cules have also been shown to bind a more di-
verse set of antigens than MHC-Ia, which bind 
only 8–10 mer peptides. For example, during 
Mycobacterium tuberculosis infection, CD1 pro-
teins present lipid molecules to T cells (6, 7). 
When mice are infected with L. monocytogenes, 
CD8+ T cells recognize formylated peptides 
bound to M3 (8).
Although our knowledge of most MHC-Ib 
molecules is limited, M3 has been studied in 
great detail. The peptide-binding groove of 
M3 is shallower than classical MHC-I molecules 
and it has been demonstrated to   specifi  cally 
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bind short (5–6 mer) hydrophobic peptides with an NH2-
  terminal formylated methionine (9–11). It has been suggested 
that M3 evolved specifi  cally to present bacterial antigens to 
the mammalian immune system   because  N-formylation is 
used as a signal to initiate protein synthesis only in prokary-
otes and for a limited set of mitochondrial and chloroplast 
proteins. At least three formylated peptides derived from 
L. monocytogenes (fMIVIL, fMIGWII, and fMIVTLF) have 
been shown to bind M3, and T cells that recognize each of 
these peptides are known to be activated during Listeria infec-
tion (12–14). In fact, in BALB/c mice, the magnitude of the 
fMIGWII-specifi  c T cell response is nearly as great as the im-
munodominant Kd-binding LLO91-99 T cell response (8).
Using MHC-Ia–defi   cient mice, we and others have 
shown that MHC-Ib–restricted CD8+ T cells alone are suffi   -
cient to clear infection with the intracellular bacterial patho-
gen L. monocytogenes (15, 16). It has been suggested that 
M3-restricted T cells are largely responsible for this protec-
tive immunity in mice (17). If this were true, use of the 
L. monocytogenes murine infection model would be more lim-
ited as a tool to study the role of MHC-Ib–restricted T cells 
in human immunity against intracellular pathogens because 
no human homologue for M3 has yet been discovered.
The purpose of this study was to determine whether 
MHC-Ib molecules other than M3 could mediate protective 
immunity against L. monocytogenes infection. We used an ac-
tinonin resistance selection strategy to generate mutant strains 
of L. monocytogenes that lacked the necessary enzyme systems 
to incorporate formylmethionine at the NH2 terminus of 
newly synthesized proteins. Mice infected with these mutant 
strains were therefore unable to present formylated peptide 
antigens derived from L. monocytogenes to naive M3-restricted 
CD8+ T cells. We found that activation and proliferation of 
M3-restricted CD8+ T cells was not required for protective 
immunity against Listeria in MHC-Ia–defi  cient mice, sug-
gesting that other MHC-Ib must be capable of presenting 
antigens to T cells and stimulating a memory CD8+ T cell 
response. These data underscore the importance of discovering 
new classes of MHC-Ib molecules and identifying the types 
of antigens presented by these MHC-Ib family members.
RESULTS
Selection of L. monocytogenes strains containing 
formyltransferase (fmt) mutations
Previous studies have shown that formylation is not essential 
for initiation of protein synthesis in either Pseudomonas aerugi-
nosa (18) or Staphylococcus aureus (19). We predicted that for-
mylation would similarly not be required for protein synthesis 
in L. monocytogenes and that it would be possible to select for 
a mutant strain incapable of formylating nascent polypep-
tides. Such a strain could then be used as a tool to determine 
the role of M3-restricted T cells in MHC-Ib–mediated anti-
Listeria immunity. We used actinonin, a naturally occurring 
peptide deformlyase (PDF) inhibitor (20), to select for sponta-
neous fmt mutants in Listeria. Failure to remove formyl groups 
from the NH2-terminal methionine of newly synthesized 
proteins is toxic to most bacteria; however, if formyl groups 
are never added, then PDF activity would not be required, 
and bacteria should grow readily in the presence of actinonin 
(Fig. 1). Margolis et al. previously showed that growth of 
S. aureus in the presence of actinonin resulted in the appear-
ance of actinonin-resistant (ActR) colonies that had sponta-
neous mutations in the S. aureus fmt gene (19). We used a 
similar selection strategy to isolate Listeria fmt mutants.
Wild-type L. monocytogenes 10403s was plated on brain–
heart infusion (BHI) agar containing 100 μg/ml actinonin. 
Spontaneous ActR colonies arose at a frequency of 1.25 × 
10−6. Three ActR colonies were passaged 25 times on BHI 
plates lacking antibiotics and inoculated onto BHI agar with 
or without actinonin. No actinonin-sensitive revertants were 
observed and the resulting strains were named L. monocyto-
genes SD-A1, SD-A4, and SD-A8. DNA sequence analysis 
revealed that all three ActR strains contained frameshift mu-
tations in the fmt gene (Table I). Strains SD-A1, SD-A4, and 
SD-A8 were each predicted to encode methionyl-tRNAfMet 
formyltransferase (MTF) proteins truncated at the COOH 
terminus. The COOH-terminal portion of MTF is thought 
to be necessary for binding to methionine-loaded tRNAfMet 
(21); therefore, these truncated proteins should lack the abil-
ity to formylate nascent polypeptides.
Figure 1.  Actinonin inhibits bacterial peptide deformylase (PDF) 
activity. Bacterial methionyl-tRNAfMet formyltransferase (MTF) adds a 
formyl group to methionines that are bound to initiator tRNAs. For-
mylation promotes binding of initiator factor 2 (IF-2) and impairs binding 
of elongation factor Tu and, therefore, provides a basis for the initiation 
of protein synthesis. The formyl group is cleaved from the mature protein 
by peptide deformylase (PDF), and in many cases the NH2-terminal methi-
onine is removed by methionine amino peptidase (not depicted). Actino-
nin is a naturally occurring inhibitor of metallohydrolases that blocks PDF 
activity in bacteria (reference 20).
Table I. Characterization of actinonin-resistant 
L. monocytogenes strains
Strain  fmt genotype Composition of predicted
MTF protein
10403s Wild type Complete coding sequence, 
 313  aa
SD-A1 Insertion (G) at bp 514a Frameshift after 171 aa
SD-A4 Deletion (A) at bp 267 Frameshift after 89 aa
SD-A8 Insertion (G) at bp 396 Frameshift after 132 aa
abp refer to the nucleotide position within the 939 bp of the wt fmt ORF.JEM VOL. 203, February 20, 2006  385
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fmt mutant L. monocytogenes have an increased doubling 
time compared with wild-type L. monocytogenes
After 24–48 h of incubation at 37°C on BHI agar, colonies of 
the fmt mutant L. monocytogenes grew to only approximately 
half the size of wild-type Listeria colonies, suggesting that the 
fmt mutants had a slower growth rate. In fact, all three fmt 
mutant strains had a twofold increase in doubling time when 
grown in BHI broth (Fig. 2). Even after 48 h of incubation, 
growth of the fmt mutant strains did not reach the same den-
sity as wild-type L. monocytogenes (unpublished data). Slower 
growth rates have also been observed for fmt mutant strains of 
P. aeuruginosa (18) and S. aureus (19). Collectively, these re-
sults suggest that using formylation to initiate protein syn-
thesis enhances bacterial growth, but that formylation is not 
essential for in vitro growth of these bacteria.
No intracellular growth defect is observed for fmt 
mutant L. monocytogenes
Wild-type L. monocytogenes encode several virulence factors 
that allow the bacteria to readily enter mammalian cells, es-
cape from endocytic vesicles, and grow within the cytoplasm 
of infected cells. As shown in Fig. 3, we tested a variety of 
diff  erent cell types and found no diff  erence in the ability of 
either fmt mutant or wild-type Listeria strains to replicate in-
side cells. In both L2 fi  broblasts (Fig. 3 A) and Hepa1-6 liver 
epithelial cells (Fig. 3 B), the growth rate for strains SD-A1 
and SD-A8 was indistinguishable from the wild-type strain 
10403s. In J774 macrophage-like cells, we recovered fewer 
intracellular fmt mutant Listeria than wild-type Listeria 1 h after 
infection (Fig. 3 C). However, the growth rate over the next 
7 h in J774 cells was the same for all three strains. These data 
demonstrate that intracellular growth of the fmt mutant Liste-
ria strains was not impaired compared with wild-type Listeria.
N-formylated peptides do not accumulate in the 
supernatants of fmt mutant Listeria cultures
Formylated MIGWII (f-MIGWII), an M3-binding peptide 
derived from the L. monocytogenes LemA protein, has been 
shown to accumulate over time in the culture supernatant 
when L. monocytogenes is grown in broth (22). The mecha-
nism for this accumulation of formylated peptide is not 
known, but it is thought that extracellular proteases could 
cleave the NH2-terminal portion of LemA, which is pre-
dicted to have an “Nout” topology. Presumably, this orienta-
tion protects the formyl group on the peptide from PDF 
activity in the bacterial cytoplasm. To ensure that formylation 
was not occurring in the fmt mutant strains, we used a T cell 
cytotoxicity assay to measure the amount of fMIGWII pep-
tide found in either wild-type or fmt mutant Listeria culture 
supernatants. Target cells were pretreated with Listeria cul-
ture supernatant and exposed to the fMIGWII-specifi  c CD8+ 
T cell line S172. Line S172 is able to lyse   target cells coated 
Figure 2.  The doubling time of fmt mutant Listeria is increased 
compared with wild-type Listeria during growth in BHI broth. 
Freshly streaked wild-type (Lm 10403s) or fmt mutant (SD-A1, SD-A4, 
SD-A8) L. monocytogenes strains were incubated overnight at 37°C with 
aeration in BHI broth. The next day, each culture was diluted to an OD550 
of  0.015 in fresh BHI broth and further incubated at 37°C with aeration. 
Bacterial growth was assessed by determining the OD550 at various time 
points as indicated. Representative data from one of two different 
  experiments are shown.
Figure 3.  fmt mutant Listeria do not have a replication defect 
during intracellular growth. Monolayers of L2 fi  broblasts, Hepa1-6 
epithelial cells, or J774 macrophage-like cells plated on glass coverslips 
were infected with the Listeria strains indicated for 30 min, washed ex-
tensively, and incubated in media containing 25 μg/ml gentamicin to kill 
extracellular bacteria. At each of the time points indicated, the cells at-
tached to each coverslip were lysed in sterile water to release intracellular 
bacteria. Serial dilutions of each lysate were plated on BHI agar to deter-
mine the total number of bacterial colony forming units (CFU) associated 
with each coverslip. Data shown represent the average values ± SD for 
triplicate coverslips from one of two separate experiments.386  MTF MUTANT LISTERIA LACK M3-BINDING PEPTIDES | D’Orazio et al.
with picomolar or greater concentrations of formylated 
MIGWII peptide but not unformylated peptide (Fig. 4 B). As 
shown in Fig. 4 A, line S172 CD8+ T cells lysed target cells 
treated with supernatant from wild-type Listeria, but did not 
lyse targets treated with either SD-A1 or SD-A8 supernatant. 
In addition, the CD8+ T cell clone 2.5, which recognizes an 
as yet unidentifi  ed Listeria antigen bound to M3 (unpublished 
data) was also not capable of lysing target cells treated with 
supernatant from fmt mutant Listeria. The lower limit of de-
tection for the recognition of formylated peptides by CD8+ 
T cells using the cytotoxicity assay was 10−11M (Fig. 4 B). 
These results suggested that N-formylated proteins were not 
present in the fmt mutant Listeria strains to provide a source of 
M3-binding peptides.
fmt mutant Listeria establish infection in mouse spleen, 
but have an impaired ability to replicate in mouse liver
Before characterizing the adaptive immune response against 
the fmt mutant Listeria in vivo, we fi  rst tested whether or not 
the fmt mutant strains were virulent enough to establish a 
sustained infection in mice that would allow for processing 
and presentation of bacterial antigens to the immune system. 
We used a competitive index assay to compare the virulence 
of the fmt mutant strains to wild-type L. monocytogenes DP-
L3903. BALB/c mice were infected with a 1:1 mixture of 
wild-type (erythromycin-resistant) and fmt mutant L. monocy-
togenes (erythromycin-sensitive). 3 d later, liver and spleen 
homogenates from each mouse were diff  erentially plated on 
media with or without erythromycin to determine the total 
number of CFU of each Listeria strain present. As shown in 
Fig. 5 A, approximately equal numbers of wild-type and fmt 
mutant L. monocytogenes were recovered from the spleen of 
each mouse, indicating that fmt mutant Listeria were fully able 
to compete with wild-type Listeria for growth in the spleen. 
However, at least 10-fold fewer SD-A1 or SD-A8 L. monocy-
togenes were recovered from mouse livers compared with 
wild-type Listeria (Fig. 5 A), suggesting that the fmt mutant 
strains were less virulent in the liver and not able to compete 
with wild-type L. monocytogenes for growth.
A growth defect in the liver, but not the spleen, has also 
been observed for L. monocytogenes strains with mutations in 
the actA gene (23). ActA mutants are unable to spread effi   -
ciently from cell to cell and form smaller plaques than wild-
type L. monocytogenes when assayed on cell monolayers. 
Similarly, we have observed that fmt mutant Listeria formed 
Figure 4.  Formylated peptides do not accumulate in the culture 
supernatants of fmt mutant Listeria strains. T cell recognition of tar-
get cells was measured as a function of cytotoxicity (51Cr release into the 
supernatant) and is shown as percentage of specifi  c lysis. (A) 51Cr-loaded 
EL-4 target cells were pretreated with media alone (BHI broth) or culture 
supernatant derived from either wild-type (wt Lm) or fmt mutant 
(SD-A1, SD-A8) L. monocytogenes strains. CD8+ T cells were added at 
various effector to target ratios and the cells were coincubated for 4 h. 
Line S172 T cells recognize N-formylated MIGWII peptide bound to M3; 
clone 2.5 is an M3-restricted CD8+ T clone of unknown specifi  city. (B) 
51Cr-loaded EL-4 target cells were pretreated with synthetic peptide at 
the fi  nal   concentrations indicated. Line S172 T cells were added at an 
effector: target ratio of 45:1.
Figure 5.  fmt mutant Listeria are less virulent in the liver than in 
the spleen. (A) A competitive index assay was used to determine the 
relative virulence of fmt mutant Listeria strains SD-A1 and SD-A8 com-
pared with wild-type Listeria. BALB/c mice were sublethally infected intra-
venously with a 1:1 mixture of wild-type (erythromycin-resistant) and 
mutant Listeria (erythromycin-sensitive). Mice were killed 3 d later and 
the spleens and livers were homogenized and differentially plated to de-
termine the total number of each bacterial strain present. Squares repre-
sent competitive indices for individual mice; thick black lines represent 
average indices for groups of mice. (B) A plaque assay was used to assess 
the degree of cell-to-spread achieved by fmt mutant Lm SD-A1 compared 
with wild-type Lm 10403s. Confl  uent monolayers of L2 fi  broblasts were 
infected at low MOI (0.1) for 1 h and agarose overlays were added. After 
3 d of incubation at 37°C in 7% CO2, neutral red overlays were added to 
visualize the plaques. Plaque size indicates the relative degree of cell-to-
cell spread for each strain. Infections were performed in duplicate wells in 
two separate experiments.JEM VOL. 203, February 20, 2006  387
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plaques in cell monolayers that were only half the size of 
plaques formed by wild-type L. monocytogenes (Fig. 5 B). In 
L2 fi  broblasts, strains SD-A1 and SD-A8 formed plaques that 
were 63% and 54% of wild-type size, respectively. Similar re-
sults were observed when monolayers of Hepa1-6 epithelial 
cells were infected with L. monocytogenes fmt mutants (55% for 
SD-A1 and 61% for SD-A8). Collectively, these results sug-
gest that fmt mutant Listeria are readily able to infect single 
cells but that their ability to spread to adjacent cells is im-
paired compared with wild-type L. monocytogenes.
M3-restricted CD8+ T cells are not activated in mice 
immunized with fmt mutant L. monocytogenes
To confi  rm that M3-restricted CD8+ T cells were not acti-
vated in mice infected with fmt mutant Listeria, we harvested 
splenocytes from mice 7 d after infection and determined 
the number of fMIGWII-specifi  c CD8+ T cells present. In 
naive BALB/c mice,  0.3% of all CD8+ T cells secreted 
IFNγ after incubation with fMIGWII, the immunodominant 
M3-binding peptide epitope derived from L. monocytogenes 
(Fig. 6 A and Fig. S1, available at http://www.jem.org/cgi/ 
content/full/jem.20052256/DC1). 7 d after infection with 
wild-type  Listeria, those T cells had expanded  10-fold. 
However, no increase in the number of fMIGWII-specifi  c T 
cells was observed in spleens of BALB/c mice infected with 
either SD-A1 or SD-A8. Similar results were observed when 
MHC-Ia–defi  cient mice were used (unpublished data). As 
a control, we also counted the number of LLO91-99-specifi  c 
CD8+ T cells found in the spleens of BALB/c mice infected 
with either wild-type or fmt mutant Listeria. A signifi  cant in-
crease in the number of LLO91-99-specifi  c CD8+ T cells was 
observed after infection with all three Listeria strains (Fig. 6 A). 
Therefore, the fmt mutant Listeria were able to infect enough 
cells to allow for suffi   cient processing and presentation of a 
MHC-Ia (Kd)-binding peptide to naive CD8+ T cells.
Although the fmt mutant Listeria did not appear to be pro-
ducing formylated MIGWII peptide antigen, signifi  cant quan-
tities of unformylated MIGWII peptide could be present in the 
cytoplasm of cells infected with either strain SD-A1 or SD-A8. 
Unformylated peptides bind to M3 with a much lower af-
fi  nity than formylated peptides, and it has been thought that 
unformylated peptide bound to M3 would not stimulate naive 
CD8+ T cells in vivo. To verify that infection with fmt mu-
tant Listeria did not result in activation of any M3-restricted 
MIGWII-specifi  c CD8+ T cells, we also counted the number 
of T cells present that could recognize unformylated MIGWII 
peptide. Splenocytes harvested from mice infected with wild-
type or fmt mutant Listeria 7 d earlier were exposed to high 
concentrations of either fMIGWII or MIGWII and the num-
ber of CD8+ T cells that produced IFNγ in response to these 
stimuli was assessed by intracellular cytokine staining (ICCS). 
As shown in Fig. 6 B, the number of MIGWII-specifi  c T cells 
present in the spleens of mice infected with either strain SD-
A1 or SD-A8 did not change over background levels. These 
results suggested that M3-restricted naive CD8+ T cells are not 
activated in mice infected with fmt mutant L. monocytogenes.
To determine whether CD8+ T cells restricted by other 
MHC-Ib molecules were being activated in the absence of an 
M3-restricted T cell response, we infected MHC-Ia–defi  cient 
mice with a sublethal dose of L. monocytogenes SD-A1. 7 d 
later, splenocytes from these mice were incubated with either 
uninfected bone marrow–derived macrophages (BMMΦ) or 
cells that had been infected with fmt mutant Listeria strain 
SD-A1. As shown in Fig. 7 A and Fig. S2 (available at http://
www.jem.org/cgi/content/full/jem.20052256/DC1), a sig-
nifi  cant number of CD8+ T cells capable of recognizing an-
tigens derived from L. monocytogenes SD-A1 were found in 
the spleens of MHC-Ia–defi  cient mice. Recognition of these 
antigens was not blocked by the addition of either anti-M3 or 
anti–Qa-1b antibody. Control groups of mice infected with 
wild-type Listeria also displayed signifi  cant T cell recognition 
of infected BMMΦ. However, as expected, pretreatment 
with anti-M3 antibody blocked recognition and subsequent 
IFNγ expression for a large fraction of the CD8+ T cells 
found in these mice (Fig. 7 B). These results suggest that 
other antigens besides formylated peptides were presented 
Figure 6.  M3-restricted CD8+ T cells are not activated during 
infection with fmt mutant Listeria. Mice were immunized with PBS 
(naive group) or a sublethal dose of either wild-type (10403s) or fmt mu-
tant (SD-A1, SD-A8) L. monocytogenes. 7 d later, the mice were killed and 
the number of antigen-specifi  c CD8+ T cells present in the spleen was 
determined by IFNγ ICCS. (A) BALB/c splenocytes were exposed to either 
1 μM LLO91-99 peptide, which binds to Kd (black bars) or 1 μM fMIGWII 
peptide, which binds to M3 (white bars). (B) MHC-Ia–defi  cient splenocytes 
were incubated with either no peptide (gray bars), 1 μM formylated 
fMIGWII peptide (black bars), or 1 μM unformylated MIGWII peptide 
(white bars). Data shown represent the average number of CD8β
+ cells 
that were IFNγ+ within each group of mice ± SE from one of three 
 separate  experiments.388  MTF MUTANT LISTERIA LACK M3-BINDING PEPTIDES | D’Orazio et al.
to CD8+ T cells by novel MHC-Ib molecules during both 
wild-type and fmt mutant Listeria infection of mice.
Class Ia MHC-defi  cient mice immunized with fmt mutant 
Listeria develop protective immunity against infection with 
wild-type Listeria
MHC-Ia–defi  cient mice are able to clear secondary lethal 
challenge with L. monocytogenes as rapidly as wild-type mice 
(15, 16) and it has been suggested that M3-restricted CD8+ 
T cells are largely responsible for this protective immunity 
(17). We used the fmt mutant strains of Listeria to determine 
whether activation of M3-restricted T cells was required for 
protection against secondary Listeria infection in MHC-Ia–
defi  cient mice. Groups of MHC-Ia–defi  cient mice were im-
munized with a sublethal dose of either wild-type or fmt 
mutant L. monocytogenes; a control group (naive mice) re-
ceived PBS. 3 wk later, all groups of mice were challenged 
with 5 LD50 of wild-type L. monocytogenes 10403s. 3 d later, 
the total number of Listeria CFU present in the spleen or liver 
was determined. Mice immunized with wild-type Listeria 
had at least two logs fewer bacteria in the spleen or liver com-
pared with naive mice (Fig. 8). Surprisingly, mice immunized 
with either SD-A1 or SD-A8 showed the same degree of 
protection against high dose secondary infection as was ob-
served after immunization with wild-type L. monocytogenes. 
This result indicates that activation of M3-restricted CD8+ 
T cells was not essential for protective immunity against 
L. monoytogenes in these mice and suggests that other MHC-
Ib–restricted T cells may have a signifi  cant role in the clear-
ance of Listeria infection.
D  I  S  C  U  S  S  I  O  N 
We isolated ActR fmt mutant strains of L. monocytogenes to use 
as a tool to address the role of M3-restricted CD8+ T cells in 
MHC-Ib–mediated protective immunity against intracellular 
bacterial pathogens. While performing assays to characterize 
these fmt mutant strains, we discovered several interesting 
phenotypes. For example, although the fmt mutant strains 
were able to compete with wild-type L. monocytogenes for 
growth in the spleen, signifi  cantly fewer fmt mutant Listeria 
were isolated from the liver. This diff  erence in virulence can 
be at least partially explained by the observation that fmt mu-
tant Listeria have a reduced ability to spread from cell-to-cell. 
One mechanism for Listeria to prolong survival in the host is 
thought to be the ability of the bacteria to spread to a neigh-
boring cell without encountering the extracellular environ-
ment, where the bacteria are susceptible to phagocytosis by 
activated macrophages or neutrophils. Hepatocytes, which 
are readily infected by L. monocytogenes, are connected by cell 
junctions within the tissue, and this cell-to-cell contact pre-
sumably facilitates spread of the bacteria within the liver. In 
contrast, L. monocytogenes infects primarily circulating im-
mune cells (monocytes, macrophages, and dendritic cells) in 
the spleen. Thus, the apparent increased virulence of the fmt 
mutant L. monocytogenes in the spleen may simply refl  ect the 
fact that effi   cient cell-to-cell spread of bacteria is not an im-
portant feature for growth in the spleen.
Interestingly, the fmt mutant L. monocytogenes had a slight 
growth defect in vitro but not in vivo. It has long been 
thought that formylation of initiator Met-tRNAs is essential 
for protein synthesis in bacteria and in eukaryotic organelles 
such as chloroplasts and mitochondria. This belief is based 
largely on studies that showed a marked (>10-fold) decrease 
in growth of Escherichia coli containing mutations in fmt (24) 
and the identifi  cation of formylmethionine at the NH2 ter-
minus of several mitochondrial proteins. However, we show 
here that mutations in the L. monocytogenes fmt gene have 
Figure 7.  CD8+ T cells from fmt mutant Listeria-immune mice 
recognize antigens presented by an MHC-Ib molecule other than 
M3 or Qa-1b. Groups of MHC-Ia–defi  cient mice were infected with 
2,000 CFU of either (A) fmt mutant (Lm SD-A1) or (B) wild-type (Lm 
10403s) L. monocytogenes. 7 d after infection, splenocytes from these 
mice were harvested and exposed to MHC-Ia–defi  cient BMMΦ (either 
uninfected or cells that had been infected for 3 h with the same strain of 
Listeria used to infect the mice). As indicated, some samples of Listeria-
infected BMMΦ were pretreated with either anti-M3 or anti–Qa-1b 
monoclonal antibody before the addition of immune splenocytes. Data 
shown represent the average number of TCRβ+ CD8+ cells that stained 
IFNγ+ within each group of mice ± SE from one out of two experiments.
Figure 8.  Immunization with fmt mutant Listeria results in full 
protective immunity against secondary challenge with wild-type 
Listeria. Groups of MHC-Ia–defi  cient mice were immunized with PBS 
(naive) or 103 CFU of either 10403s (wild type) or SD-A1 (fmt mutant) 
L. monocytogenes. 3 wk later, all groups of mice were challenged intrave-
nously with 5 × 104 wild-type Listeria. The total number of CFU per organ 
was determined 3 d after infection. Similar results were observed for 
groups of mice immunized with strain SD-A8 (not depicted). Data shown 
represent average values ± SD for groups of mice from one of two 
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only a modest eff  ect on bacterial growth in BHI broth. Other 
groups have shown a similar growth phenotype in P. aerugi-
nosa (18) and S. aureus (19). These observations suggest that 
formylation may confer a slight advantage for in vitro growth 
of most bacterial species, but that only in E. coli has a strict 
requirement for fmt activity been demonstrated. Li et al. 
showed that protein synthesis could also be initiated in yeast 
mitochondria in the absence of formylated methionine (25). 
A comparative analysis of the structural requirements for 
binding of IF-2 to fMet-tRNA vs. Met-tRNA in each of 
these organisms may elucidate the mechanism whereby pro-
tein synthesis can readily initiate in the absence of formyl-
methionine in prokaryotes or in mitochondria.
It is possible that during infection of mice, secondary mu-
tations occurred that allowed the fmt mutant L. monocytogenes 
to replicate faster. However, we found that the fmt mutant 
strains were replicating at the same rate as wild-type L. mono-
cytogenes after just 1–2 h of infection of tissue culture cells. It 
does not seem likely that selective pressures could have re-
sulted in secondary mutations during this short time period. 
These data suggest that the cytoplasm of host cells may be an 
environment in which the bacterial enzymes involved in for-
mylation are not necessary. Even if secondary mutations did 
occur in vivo that resulted in a low level of formylation in the 
fmt mutant bacteria, insuffi   cient antigen was presented to ac-
tivate the immunodominant M3-restricted Listeria-specifi  c 
CD8+ T cell population.
During primary Listeria infection, M3-restricted T cells 
expand faster than Kd-restricted T cells, with peak numbers 
occurring by 5–6 d after infection (8) and it has been shown 
that M3-restricted CD8+ T cells alone can clear sublethal 
Listeria infections within 5 d (26). The role of M3-restricted 
T cells during secondary infection, however, has been less 
clear. Kerksiek et al. showed that M3-restricted memory 
CD8+ T cell populations are generated and maintained after 
primary infection with L. monocytogenes. However, despite 
the fact that these memory CD8+ T cells were activated in 
the same manner as Kd-restricted T cells, the M3-restricted 
CD8+ cells failed to undergo a dramatic proliferative burst 
upon rechallenge with Listeria (27). It has been diffi   cult to 
determine the precise role of M3-restricted CD8+ T cells 
during secondary Listeria infections because of the apparent 
paradox that M3-restricted T cells are a dominant fraction of 
the MHC-Ib–restricted T cell population (17), yet the recall 
expansion of these cells is small and perhaps not signifi  cant 
enough to clear large bacterial burdens. Hamilton et al. re-
cently suggested that it is the MHC-Ia–restricted T cell re-
sponse that limits the expansion of M3-restricted memory 
CD8+ T cells during secondary challenge (26).
In this report, we show that immunization with an fmt 
mutant Listeria strain that lacks formylated peptides still results 
in the generation of protective immunity against secondary 
Listeria infection. These data argue that activation of M3-
  restricted CD8+ T cells is not essential for protective immu-
nity against Listeria and suggests that presentation of antigen 
in the context of other MHC-Ib molecules is suffi   cient to 
elicit a protective memory CD8+ T cell response. Bouwer 
et al. previously showed that Qa-1b–restricted Listeria-specifi  c 
cytotoxic T lymphocytes increase in number during L. mono-
cytogenes infection (28). However, like M3-restricted CD8+ 
T cells, Qa-1b–restricted T cells do not expand signifi  cantly 
during secondary infection (29). We have previously shown 
that in MHC-Ia–defi  cient mice, the residual population of 
MHC-Ib–restricted CD8+ T cells does expand signifi  cantly 
after both primary and secondary Listeria infection, and that 
protective immunity is mediated by CD8+ T cells in these 
mice (15). Because neither M3-restricted nor Qa-1b–  restricted 
CD8+ T cells expand signifi  cantly during secondary Listeria 
infection, the activated population of CD8+ T cells must rec-
ognize L. monocytogenes antigens presented by novel MHC-Ib 
molecules. These MHC-Ib–restricted CD8+ T cells appear 
to be necessary for clearance of Listeria in the absence of 
MHC-Ia–restricted and M3-restricted T cell responses be-
cause adoptive transfer of L. monocytogenes SD-A1 immune 
splenocytes depleted of CD8+ T cells failed to protect naive 
mice from challenge with L. monocytogenes (Fig. S3, available 
at http://www.jem.org/cgi/content/full/jem.20052256/DC1). 
Further studies will be required to determine whether these 
additional MHC-Ib–restricted CD8+ T cell specifi  cities are 
involved in protective immunity in wild-type mice.
In the past decade, the majority of studies examining 
MHC-Ib–restricted T cells have focused on the recognition 
of formylated peptides presented by M3 molecules. The re-
sults presented here make a strong argument that a search for 
new MHC-Ib molecules capable of presenting antigen to 
CD8+ T cells would result in the identifi  cation of new anti-
genic specifi  cities able to protect against secondary Listeria 
infection. Further characterization of the unique types of an-
tigens that can be recognized by protective CD8+ T cells will 
greatly facilitate the rational design of eff  ective therapeutic 
strategies to protect against other intracellular bacteria, in-
cluding prevalent pathogens such as Mycobacterium tuberculosis 
and Chlamydia trachomatis.
MATERIALS AND METHODS
Bacteria. L. monocytogenes fmt mutant strains SD-A1, SD-A4, and SD-A8 
were derived from wild-type L. monocytogenes 10403s. L. monocytogenes 
10403s has a LD50 of  104 CFU in BALB/c mice. Bacteria were grown in 
BHI broth (Difco) supplemented with 100 μg/ml actinonin (Sigma-  Aldrich) 
as indicated. DNA fragments encoding fmt were amplifi  ed from each Listeria 
strain using Platinum PCR Supermix (Invitrogen) with the following prim-
ers: 3′-G  A  C  A  T  G  A  G  C  G  G  A  C  A  G  G  G  G  A  A  G  T  -5′ and 3′-C  A  C  C  C  C  G  T  T  G-
A  C  G  A  A  T  T  T  A  G  T  T  A  C  -5′. The DNA sequence of each PCR product was 
directly determined using internal primers. Bacterial culture supernatants 
were prepared by inoculating BHI broth and incubating with aeration at 
37°C for 24 h. Bacteria were centrifuged at 13,000 revolutions/min for 
20   min and the supernatant was collected. Aliquots were stored at −20°C 
and thawed before use.
Cell culture. EL-4 thymoma cells (H-2b), J774 macrophage-like cells, L2 
fi  broblasts, and Hepa1-6 hepatoma (epithelial) cells were obtained from the 
American Type Culture Collection and were maintained at 37°C in 7% 
CO2. EL-4 and J774 cells were grown in RP-10 media consisting of RPMI 
1640 (GIBCO BRL) supplemented with l-glutamine, Hepes, 50 μM 
2-ME, and 10% FCS; L2 and Hepa1-6 cells were grown in DMEM (GIBCO 390  MTF MUTANT LISTERIA LACK M3-BINDING PEPTIDES | D’Orazio et al.
BRL) plus 10% FCS. T cell lines were maintained by weekly restimulation 
on antigen-coated syngeneic splenocytes as described previously (15).
Mice. BALB/c/By/J mice obtained from Jackson ImmunoResearch Labo-
ratories and eleventh backcross generation C.B10-H-2b/LilMcd/J Kb−/−Db−/− 
mice (15) were housed in specifi  c pathogen-free animal facilities at Harvard 
Medical School (HMS) and the University of Kentucky (UK). The experi-
mental procedures used in this study were approved by IACUC committees 
at both HMS and UK. For primary infections, mice were given  103 CFU 
of L. monocytogenes i.v. in the tail vein. For secondary challenges, mice were 
allowed to recover for 3 wk and infected i.v. with  6 × 104 CFU L. mono-
cytogenes. 3 d after infection, spleen and livers were harvested aseptically, di-
luted in 0.2% NP-40, and plated on BHI agar to determine the total number 
of CFU per organ.
Intracellular growth assay. Cells were seeded on 12-mm round coverslips 
and incubated overnight in RP-10 without antibiotics to reach confl  uence. 
Bacteria were grown to early log phase in BHI broth, washed once with 
PBS, and used to infect cell monolayers. Cells were infected (on coverslips 
in triplicate) at a multiplicity of infection of 0.1 (for J774 cells) or 5.0 (for L2 
and Hepa1-6 cells), incubated for 30 min, washed three times with warm 
PBS, and RP-10 containing 25 μg/ml gentamicin sulfate was added. At in-
dicated time points, the number of bacteria associated with each coverslip 
was determined by placing the coverslip in sterile dH2O, vortexing vigor-
ously for 30 s, and plating dilutions on BHI agar.
T cell cytotoxicity. Target cells were coincubated with either 50 μl of 
L.  monocytogenes supernatant or synthetic peptide (Bio-Synthesis) and 
100 μCi sodium 51chromate for 1 h at 37°C in 7% CO2. The cells were 
washed three times with RPMI 1640, suspended in RP-10 at 105 cells/ml 
and 100 μl of cells per well was added to 96-well plates. Serial dilutions of 
T cells were added in a fi  nal volume of 200 μl/well and the plates were in-
cubated for 4 h at 37°C in 7% CO2. Spontaneous release was determined in 
wells containing target cells with no T cells; maximum release was deter-
mined by the addition of 1% Triton X-100. The cytotoxic activity of the 
T cells was evaluated by measuring 51Cr release in the supernatant on a Wal-
lac 1470 Wizard γ counter. Percent specifi  c lysis was calculated using the 
following formula: % specifi  c lysis = 100 × [(release by T cells −  spontaneous 
release) ÷ (maximum release − spontaneous release)].
Competitive index assay. Growth of fmt mutant Listeria strains was com-
pared with growth of wild-type Listeria using a competitive index assay as 
described previously (23). In brief, BALB/c mice were infected (i.v.) with a 
1:1 mixture of wild-type strain DP-L3903 (ErmR) and one of the fmt mutant 
strains. Mice were given a total of  103 CFU and were killed 72 h later. 
Spleens and livers were harvested aseptically, homogenized, diluted in 0.2% 
NP-40, and plated on BHI agar. At least 100 colonies per organ were replica 
plated or patched onto BHI agar containing 2 μg/ml erythromycin. Com-
petitive indices were calculated by dividing the total number of test strain 
CFU (SD-A1 or SD-A8; erythromycin-sensitive) by the total number of 
reference strain CFU (DP-L3903; erythromycin-resistant).
Plaque assay. Cells were grown to confl  uence in six-well dishes, infected 
with L. monocytogenes for 1 h at various multiplicities of infection, and washed 
three times with warm PBS. Overlays consisting of MEM (GIBCO BRL) 
containing 2.5% FBS, 1% agarose, and 10 μg/ml gentamicin sulfate were 
added and the cells were incubated for an additional 3 d. Plaques were visu-
alized by the addition of neutral red overlays (1% agarose, 0.2% neutral red 
in MEM-2.5). Plaque size was measured by analyzing digital images of the 
overlays.
ICCS. IFNγ ICCS was performed using the Cytofi  x/Cytoperm Plus (with 
GolgiPlug) kit (BD Biosciences). In brief, splenocytes were harvested from 
Listeria-infected mice and 5 × 106 cells/well were added to 24-well dishes. 
Synthetic peptides (Bio-Synthesis) corresponding to antigenic epitopes 
were added to some wells at a fi  nal concentration of 1 μM. In experiments 
where J774 cells were used as targets, 4 × 105 J774 cells per well were in-
fected with L. monocytogenes SD-A1 at a multiplicity of infection of 1.0 for 
2 h before the addition of splenocytes. Listeria culture supernatant (50 μl) 
was added directly to some wells. After 5–6 h of incubation in the pres-
ence of GolgiPlug at 37°C in 7% CO2, cells were stained with anti-CD8α 
(53–6.7), anti-CD8β (53–5.8), and anti-TCRb (H57-597) antibodies. The 
cells were fi  xed, permeabilized, and stained with anti-IFNγ (XMG1.2) an-
tibody according to the manufacturer’s instructions. Cells were suspended 
in FACS buff  er (0.5% BSA, 0.1% NaN3 in HBSS) before fl  ow cytometric 
analysis. Fluorescence intensities were measured using a FACSCalibur fl  ow 
cytometer (Becton Dickinson) and analysis was performed using CELL-
Quest software. Dead cells and monocytes were excluded using forward 
and side scatter gating. Typically, 100,000 gated events were collected for 
each analysis.
Antibody-blocking experiments. CD8+ cells were enriched from whole 
splenocytes by negative selection using antibody-conjugated IMag magnetic 
beads (BD Biosciences). Typically, the enrichment protocol removed 90–
95% of the splenocytes from MHC-Ia–defi  cient mice. Listeria-infected or 
uninfected MHC-Ia–defi  cient BMMΦ were pretreated with anti-M3 (clone 
130) or anti–Qa-1b (6A8.6F10.1A6) monoclonal antibodies (fi  nal concentra-
tion 500 μg/ml) for 30 min at room temperature. The antibodies were 
maintained at a concentration of 20 μg/ml for 5–6 h during the incubation 
of CD8-enriched splenocytes with infected or uninfected macrophages. The 
number of IFNγ-secreting CD8+ T cells was determined by ICCS as de-
scribed in the previous paragraph.
Online supplemental material. Fig. S1 displays primary dot plots from 
individual mice representative of the data shown in Fig. 6 A. Fig. S2 includes 
primary FACS plots for individual mice representative of the data shown in 
Fig. 7. Fig. S3 shows that adoptive transfer of fmt mutant Listeria-immune 
spleen depleted of CD8+ T cells does not protect mice as well as whole im-
mune spleen. Online supplemental material is available at http://www.jem.
org/cgi/content/full/jem.20052256/DC1.
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